The inhibition of ganglionic transmission via presynaptic dopamine DA1 and postsynaptic DA2 receptor activation in the canine cardiac sympathetic ganglia

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 822-829

  Mukai, M ^a   Kushiku, K ^a   Yamada, H ^a   Yamada, K ^a   Dan, K ^a   Furukawa, T ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; ACETYLCHOLINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; QUINPIROLE; SULPIRIDE; TALIPEXOLE; YOHIMBINE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; CHRONOTROPISM; DOG; DOPAMINERGIC TRANSMISSION; DRUG ANTAGONISM; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; GANGLION BLOCK; HEART INNERVATION; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SYMPATHETIC GANGLION;

(4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE; (R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ACETYLCHOLINE; ANIMALS; AZEPINES; DIMETHYLPHENYLPIPERAZINIUM IODIDE; DOGS; DOPAMINE AGONISTS; FEMALE; GANGLIA, SYMPATHETIC; HEART RATE; MALE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SULPIRIDE; SYNAPTIC TRANSMISSION;

EID: 0030426260     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ANDËN, N.-E. AND GRABOWSKA-ANDËN, M.: B-HT 920 is a full agonist at both pre-and postsynaptic D-2 dopamine receptors. J. Neural. Transm. 79: 209-214, 1990.
2. COLE, A. E. AND SHINNICK-GALLAGHER, P.: Comparison of the receptors mediating the catecholamine hyperpolarization and slow inhibitory postsynaptic potential in sympathetic ganglia. J. Pharmacol. Exp. Ther. 217: 440-444, 1981.
3. DLEWATI, A., WATKINS, H. O. AND LOKHANDWALA, M. F.: Effects of SK&F 85174, a DA1/DA2 receptor agonist, on pre- and postganglionic sympathetic neurotransmission to the heart. Eur. J. Pharmacol. 164: 197-203, 1989.
4. DOMAE, M., YAMADA, K., HANABUSA, Y., MATSUMOTO, S. AND FURUKAWA, T.: Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919. Eur. J. Pharmacol. 179: 75-82, 1990.
5. DUN, N. AND NISHI, S.: Effects of dopamine on the superior cervical ganglion of the rabbit. J. Physiol. 239: 155-164, 1974.
6. ECCLES, R. M.: Responses of isolated curarized sympathetic ganglia. J. Physiol. (Lond.) 117: 196-217, 1952.
7. ECCLES, R. M. AND LIBET, B.: Origin and blockade of the synaptic responses of curarized sympathetic ganglia. J. Physiol. (Lond.) 157: 484-503, 1961.
8. EVA, C., HADJICONSTANTINOU, M., NEFF, N. H. AND MEEK, J. L.: Acetylcholine measurement by high-performance liquid chromatography using an enzyme-loaded postcolumn reactor. Anal. Biochem. 143: 320-324, 1984.
9. FLEISCH, J. H., FLACKE, K. AND GILLIS, R. A.: Nicotinic and muscarinic receptors in the cardiac sympathetic ganglia of the dog. J. Pharmacol. Exp. Ther. 168: 106-115, 1969.
10. GINGRICH, J. A. AND CARON, M. G.: Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16: 299-321, 1993.
11. GOLDBERG, L. I. AND KOHLI, J. D.: Peripheral pre- and post-synaptic dopamine receptor: Are they different from dopamine receptors in the central nervous system? Comm. Psychopharmacol. 3: 447-456, 1979.
12. HILDITCH, A., DREW, G. M. AND NAYLOR, R. L.: SCH23390 is very potent and selective antagonist at vascular dopamine receptors. Eur. J. Pharmacol. 97: 333-334, 1984.
13. KAISER, C., DANDRIDGE, P. A., GARVEY, E., HAHN, R. A., SARAU, H. M., SETLER, P. E., BASS, L. S. AND CLARDY, J.: Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine. J. Med. Chem. 25: 697-703, 1982.
14. 2-adrenoceptor agonist and antagonist on muscarinic receptor stimulation in cardiac sympathetic ganglia of the dog. J. Cardiovasc. Pharmacol. 19: 382-386, 1992.
15. KOBINGER, W. AND PICHLER, L.: Relation between central sympathoinhibitory and peripheral pre- and postsynaptic α-adrenoceptors as evaluated by different clonidine-like substances in rats. Naunyn-Schmiedeberg Arch. Pharmacol. 315: 21-27, 1980.
16. KOHLI, J. D., METRA, M., SATOH, Y. AND GOLDBERG, L. I.: Dopamine receptors in the stellate ganglion of the dog. Eur. J. Pharmacol. 164: 265-272, 1989.
17. KUSHIKU, K., ARAKI, Y., FURUKAWA, T., IWASA, T., INOUE, N. AND MIYAMOTO, E.: Increment of calmodulin in proportion to enhancement of non-nicotinic responses after preganglionic stimulation of the dog cardiac sympathetic ganglia. J. Pharmacol. Exp. Ther. 245: 311-318, 1988.
18. 2α on the cardiac chronotropism by affecting the cardiac ganglionic transmission in spinal dogs. Life Sci. 26: 41-47, 1980.
19. KUSHIKU, K. AND FURUKAWA, T.: Possible inhibitory role of endogenous γ-aminobutyric acid in the nonnicotinic functions of dog cardiac sympathetic ganglia. J. Pharmacol. Exp. Ther. 223: 810-815, 1985.
20. KUSHIKU, K., FURUKAWA, T., ICHIMASA, S. AND KAMIYA, H.: Negative chronotropic effect of catecholamine on adrenergic receptors in cardiac ganglia in the spinal dog. J. Cardiovasc. Pharmacol. 2: 857-866, 1980.
21. 2 biosynthesis mediates presynaptic inhibition by endothelin-3 of the dog stellate ganglionic transmission. J. Pharmacol. Exp. Ther. 272: 70-76, 1995.
22. LIBET, B. AND TOSAKA, T.: Dopamine as a synaptic transmitter and modulator in sympathetic ganglia: A different mode of synaptic action. Proc. Natl. Acad. Sci. U.S.A. 67: 667-673, 1970.
23. 1) dopamine receptors in rat kidney. J. Auton. Pharmacol. 4: 273-277, 1984.
24. 2-receptors after administration of SND 919 in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 340: 21-25, 1989.
25. OHJIMI, H., KUSHIKU, K., YAMADA, H., KUWAHARA, T., KOHNO, Y. AND FURUKAWA, T.: Increase of acetylcholine release by nebracetam in dog cardiac sympathetic ganglion. J. Pharmacol. Exp. Ther. 268: 396-402, 1994.
26. POTTER, P. E., MEEK, J. L. AND NEFF, N. H.: Acetylcholine and choline in neuronal tissue measured by HPLC with electrochemical detection. J. Neurochem. 41: 188-194, 1983.
27. 2 receptor agonists and antagonists. J. Pharmacol. Exp. Ther. 236: 65-70, 1986.
28. SATOH, Y., KOHLI, D. J. AND GOLDBERG, I. L.: Effect of alpha adrenoceptor and dopamine receptor agonists and antagonist on ganglionic transmission. J. Pharmacol. Exp. Ther. 251: 253-257, 1989.
29. SHEBUSKI, R. J., FULITA, T., SMITH, J. M., KOPACIEWICZ, L. J., BLUMBERG, A. L. AND HIEBLE, J. P.: Suppression of sympathetic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F82526) in the anesthetized dog. J. Pharmacol. Exp. Ther. 235: 735-740, 1985.
30. TSUTSUMI, S., KUSHIKU, K., KUWAHARA, T., TOKUNAGA, R. AND FURUKAWA, T.: Ionotropic mechanisms involved in postsynaptic inhibition by the endothelins of ganglionic transmission in dog cardiac sympathetic ganglia. J. Cardiovasc. Pharmacol. 26: 707-713, 1995.
31. VAN MEEL, J. C. A., D. E. JONGE, A., TIMMERMANS, P. B. M. W. M. AND VAN ZWIETEN, P. A.: Selectivity of some alpha adrenoceptor agonists for peripheral alpha-1 and alpha-2 adrenoceptors in the normotensive rat. J. Pharmacol. Exp. Ther. 219: 760-767, 1981.